Khan Najat

Officer at RXRX

Sold, on record
$1M
Dollars the filings state
Form 4 sales
5
Latest Sep 8, 2026
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • RXRXRECURSION PHARMACEUTICALS, INC.Officer

Sales by reason

4
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice RXRXNotice
    Dec 22, 2025 2025

    Filed to sell 124,403 shares ($549k)

    Khan Najat, Officer

    10b5-1 planFiling

  2. 2 Form 4 sale RXRXRoutine
    Dec 22, 2025 same day

    Sold 124,403 shares at $4.41 ($549k)

    Khan Najat, Chief R&D Commercial Officer

    10b5-1 planSold 16.9% of holdings ($3.2M position)611,135 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice RXRXNotice
    Mar 9, 2026 +77 days

    Filed to sell 28,298 shares ($95k)

    Khan Najat, Officer

    10b5-1 planFiling

  4. 4 Form 4 sale RXRXRoutine
    Mar 9, 2026 same day

    Sold 28,298 shares at $3.35 ($95k)

    Khan Najat, CEO and President

    10b5-1 planSold 1.2% of holdings ($7.7M position)2.3M shares leftFollows a Form 144Filing

  5. 5 Form 144 notice RXRXNotice
    Jun 5, 2026 +88 days

    Filed to sell 23,588 shares ($84k)

    Khan Najat, Officer

    10b5-1 plan0.6x usual sizeFiling

  6. 6 Form 4 sale RXRXRoutine
    Jun 5, 2026 same day

    Sold 23,588 shares at $3.58 ($84k)

    Khan Najat, CEO and President

    10b5-1 planSold 1.1% of holdings ($7.9M position)2.2M shares left0.6x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice RXRXNotice
    Sep 8, 2026 +95 days

    Filed to sell 22,408 shares ($79k)

    Khan Najat, Officer

    10b5-1 plan0.7x usual sizeFiling

  8. 8 Form 4 sale RXRXRoutine
    Sep 8, 2026 same day

    Sold 22,408 shares at $3.52 ($79k)

    Khan Najat, CEO and President

    10b5-1 planSold 1.1% of holdings ($7.4M position)2.1M shares left0.7x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Khan Najat
Source
Sep 8, 2026Sep 10, 2026RXRXCEO and PresidentForm 4 sale22,408$79k1.1%RoutineSEC
Sep 8, 2026Sep 8, 2026RXRXOfficerForm 144 notice22,408$79kNoticeSEC
Jun 5, 2026Jun 5, 2026RXRXCEO and PresidentForm 4 sale23,588$84k1.1%RoutineSEC
Jun 5, 2026Jun 5, 2026RXRXOfficerForm 144 notice23,588$84kNoticeSEC
Mar 9, 2026Mar 11, 2026RXRXCEO and PresidentForm 4 sale28,298$95k1.2%RoutineSEC
Mar 9, 2026Mar 9, 2026RXRXOfficerForm 144 notice28,298$95kNoticeSEC
Dec 22, 2025Dec 29, 2025RXRXChief R&D Commercial OfficerForm 4 sale124,403$549k16.9%RoutineSEC
Dec 22, 2025Dec 22, 2025RXRXOfficerForm 144 notice124,403$549kNoticeSEC
Aug 18, 2025Aug 19, 2025RXRXChief R&D Commercial OfficerForm 4 sale36,599$202k5.2%No planSEC
Aug 18, 2025Aug 18, 2025RXRXOfficer, DirectorForm 144 notice36,599$202kNoticeSEC